Zenas Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$22.30

-1.07 (-4.58%)

As of Mar 22, 10:15 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +32.3% upside

Low Target $22.12

Average Target $29.51

High Target $35.27

Current Price $22.30

Current
$22.30

Target
$29.51

$22.12 $29.51 avg $35.27

Scenario Analysis

Bear Case

$22.12

-0.8%

Low target

Base Case

$29.51

+32.3%

Avg target

Bull Case

$35.27

+58.2%

High target

Risk/Reward

72.1x

Highly favorable

Price in Context

52-Week High

$44.60

-50.0% from high

52-Week Low

$6.11

+265.0% from low

Target vs 52W High

$29.51

-33.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%